Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5867

1.

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder.

Gautam M, Prabhakar D.

Prim Care Companion CNS Disord. 2018 Dec 27;20(6). pii: 18r02345. doi: 10.4088/PCC.18r02345. Review.

2.

Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD).

Perugi G, Pallucchini A, Rizzato S, De Rossi P, Sani G, Maremmani AG, Pinzone V, Maremmani I.

Expert Opin Pharmacother. 2019 Feb;20(3):343-355. doi: 10.1080/14656566.2018.1551878. Epub 2018 Dec 4. Review.

PMID:
30513231
3.

Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Carbray JA.

J Psychosoc Nurs Ment Health Serv. 2018 Dec 1;56(12):7-10. doi: 10.3928/02793695-20181112-02.

PMID:
30500061
4.

Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.

Layton TJ, Barnett ML, Hicks TR, Jena AB.

N Engl J Med. 2018 Nov 29;379(22):2122-2130. doi: 10.1056/NEJMoa1806828.

PMID:
30485780
5.

Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder: lessons from CNTNAP2, ADGRL3, and PARK2.

Dalla Vecchia E, Mortimer N, Palladino VS, Kittel-Schneider S, Lesch KP, Reif A, Schenck A, Norton WHJ.

Psychiatr Genet. 2019 Feb;29(1):1-17. doi: 10.1097/YPG.0000000000000211. Review.

PMID:
30376466
6.

Testing the Efficacy of a Smartphone Application in Improving Medication Adherence, Among Children with ADHD.

Weisman O, Schonherz Y, Harel T, Efron M, Elazar M, Gothelf D.

Isr J Psychiatry Relat Sci. 2018;55(2):59-63.

7.

A large-scale integrative analysis of GWAS and common meQTLs across whole life course identifies genes, pathways and tissue/cell types for three major psychiatric disorders.

Zhao Y, Liang X, Zhu F, Wen Y, Xu J, Yang J, Ding M, Cheng B, Ma M, Zhang L, Cheng S, Wu C, Wang S, Wang X, Ning Y, Guo X, Zhang F.

Neurosci Biobehav Rev. 2018 Dec;95:347-352. doi: 10.1016/j.neubiorev.2018.10.005. Epub 2018 Oct 16. Review.

8.

Behavioral Versus Nonbehavioral Guided Self-Help for Parents of Children With Externalizing Disorders in a Randomized Controlled Trial.

Hautmann C, Dose C, Duda-Kirchhof K, Greimel L, Hellmich M, Imort S, Katzmann J, Pinior J, Scholz K, Schürmann S, Wolff Metternich-Kaizman T, Döpfner M.

Behav Ther. 2018 Nov;49(6):951-965. doi: 10.1016/j.beth.2018.02.002. Epub 2018 Feb 13.

PMID:
30316493
9.
10.

How early media exposure may affect cognitive function: A review of results from observations in humans and experiments in mice.

Christakis DA, Ramirez JSB, Ferguson SM, Ravinder S, Ramirez JM.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):9851-9858. doi: 10.1073/pnas.1711548115. Review.

11.

Screen media use and ADHD-related behaviors: Four decades of research.

Beyens I, Valkenburg PM, Piotrowski JT.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):9875-9881. doi: 10.1073/pnas.1611611114. Review.

12.

Temporal discounting and attention-deficit/hyperactivity disorder in childhood: reasons for devising different tasks.

Utsumi DA, Miranda MC.

Trends Psychiatry Psychother. 2018 Jul-Sep;40(3):248-252. doi: 10.1590/2237-6089-2017-0094. Epub 2018 Sep 17. Review.

13.

The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.

Rabinowitz JA, Musci RJ, Milam AJ, Benke K, Uhl GR, Sisto DY, Ialongo NS, Maher BS.

Drug Alcohol Depend. 2018 Oct 1;191:365-373. doi: 10.1016/j.drugalcdep.2018.07.016. Epub 2018 Aug 25.

PMID:
30195949
14.

Growing out of attention deficit hyperactivity disorder: Insights from the 'remitted' brain.

Sudre G, Mangalmurti A, Shaw P.

Neurosci Biobehav Rev. 2018 Nov;94:198-209. doi: 10.1016/j.neubiorev.2018.08.010. Epub 2018 Sep 5. Review.

PMID:
30194962
15.

The efficacy of Ritalin in ADHD children under neurofeedback training.

Pakdaman F, Irani F, Tajikzadeh F, Jabalkandi SA.

Neurol Sci. 2018 Dec;39(12):2071-2078. doi: 10.1007/s10072-018-3539-3. Epub 2018 Sep 5.

PMID:
30187306
16.

ADHD prevalence estimates in Italian children and adolescents: a methodological issue.

Reale L, Bonati M.

Ital J Pediatr. 2018 Sep 5;44(1):108. doi: 10.1186/s13052-018-0545-2. Review.

17.

Comparing Alliance in Two Cognitive-Behavioural Therapies for Adolescents With ADHD Using a Randomized Controlled Trial.

Boyer B, MacKay KJ, McLeod BD, van der Oord S.

Behav Ther. 2018 Sep;49(5):781-795. doi: 10.1016/j.beth.2018.01.003. Epub 2018 Jan 31.

PMID:
30146144
18.

Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.

Teuscher NS, Sikes CR, McMahen R, Engelking D.

J Clin Psychopharmacol. 2018 Oct;38(5):467-474. doi: 10.1097/JCP.0000000000000944.

PMID:
30119076
19.

Update on Common Psychiatric Medications for Children.

Sharma A.

Pediatr Ann. 2018 Aug 1;47(8):e311-e316. doi: 10.3928/19382359-20180702-01. Review.

PMID:
30102754
20.

Management of Attention Deficit Hyperactivity Disorder During Pregnancy.

Baker AS, Freeman MP.

Obstet Gynecol Clin North Am. 2018 Sep;45(3):495-509. doi: 10.1016/j.ogc.2018.04.010. Review.

PMID:
30092924

Supplemental Content

Loading ...
Support Center